Literature DB >> 16403405

Myelodysplastic syndromes clinical practice guidelines in oncology.

Peter L Greenberg1, Maria R Baer, John M Bennett, Clara D Bloomfield, Carlos M De Castro, H Joachim Deeg, Marcel P Devetten, Peter D Emanuel, Harry P Erba, Eli Estey, James Foran, Steven D Gore, Michael Millenson, Willlis H Navarro, Stephen D Nimer, Margaret R O'Donnell, Hussain I Saba, Kathy Spiers, Richard M Stone, Martin S Tallman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16403405

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  13 in total

Review 1.  Optimizing therapy for iron overload in the myelodysplastic syndromes: recent developments.

Authors:  Heather A Leitch
Journal:  Drugs       Date:  2011-01-22       Impact factor: 9.546

Review 2.  Hematopoietic stem cell transplantation for MDS.

Authors:  Matthias Bartenstein; H Joachim Deeg
Journal:  Hematol Oncol Clin North Am       Date:  2010-04       Impact factor: 3.722

Review 3.  Optimal management strategies for chronic iron overload.

Authors:  James C Barton
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 4.  Allogeneic hematopoietic cell transplantation for MDS: for whom, when and how?

Authors:  Boglarka Gyurkocza; H Joachim Deeg
Journal:  Blood Rev       Date:  2012-09-13       Impact factor: 8.250

5.  Prospective international validation of the Quality of Life in Myelodysplasia Scale (QUALMS).

Authors:  Gregory A Abel; Fabio Efficace; Rena J Buckstein; Sara Tinsley; Joseph G Jurcic; Yolanda Martins; David P Steensma; Corey D Watts; Azra Raza; Stephanie J Lee; Alan F List; Robert J Klaassen
Journal:  Haematologica       Date:  2016-03-04       Impact factor: 9.941

6.  The role of apoptosis and current therapeutic challenges in myelodysplastic syndromes.

Authors:  M Diamantidis; S Dimoudis; Ph Klonizakis; K Badekas; K Koutourli; S Haralambidou-Vranitsa; E Ioannidou-Papagiannaki
Journal:  Hippokratia       Date:  2007-10       Impact factor: 0.471

Review 7.  Chelation therapy for iron overload.

Authors:  James C Barton
Journal:  Curr Gastroenterol Rep       Date:  2007-03

Review 8.  Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes.

Authors:  Takahiro Suzuki; Masao Tomonaga; Yasushi Miyazaki; Shinji Nakao; Kazuma Ohyashiki; Itaru Matsumura; Yutaka Kohgo; Yoshiro Niitsu; Seiji Kojima; Keiya Ozawa
Journal:  Int J Hematol       Date:  2008-06-27       Impact factor: 2.490

9.  Phase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromes.

Authors:  Janice Gabrilove; Ronald Paquette; Roger M Lyons; Chaudhry Mushtaq; Mikkael A Sekeres; Dianne Tomita; Lyndah Dreiling
Journal:  Br J Haematol       Date:  2008-06-06       Impact factor: 6.998

Review 10.  Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload.

Authors:  Norbert Gattermann
Journal:  Int J Hematol       Date:  2008-06-27       Impact factor: 2.490
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.